Physician profile
Stephen Wayne Borrus
NPI 1619980307
$11,412.24
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,683 · 2020: $4,730.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,345.89 | 2019-2020 | |
| Amarin Pharma, INC. | $1,151.40 | 2019-2020 | |
| Pfizer INC. | $919.29 | 2019-2020 | |
| Novo Nordisk INC | $875.75 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $826.37 | 2019-2020 | |
| Allergan, INC. | $818.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $814.40 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $740.81 | 2019-2020 | |
| Lilly USA, LLC | $574.35 | 2019-2020 | |
| Abbvie INC. | $517.34 | 2019-2020 | |
| Glaxosmithkline, LLC. | $441.10 | 2019-2020 | |
| Astellas Pharma US INC | $324.52 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $316.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $223.76 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $199.38 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avanir Pharmaceuticals, INC. | $192.77 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $166.28 | 2019-2020 | |
| Boston Scientific Corporation | $148.55 | 2019-2020 | |
| Valeritas, INC. | $125.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Genentech USA, INC. | $118.74 | 2020 | |
| Quidel Corporation | $91.95 | 2019 | |
| Merck Sharp & Dohme LLC | $81.83 | 2019-2020 | |
| Si-Bone, INC. | $76.42 | 2020 | |
| Eisai INC. | $55.19 | 2019-2020 | |
| Sanofi Pasteur INC. | $54.17 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.74 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.95 | 2019 | |
| Ibsa Pharma INC. | $13.75 | 2019 | |
| Nestle Healthcare Nutrition INC. | $13.32 | 2020 | |
| Stimwave Technologies Incorporated | $11.73 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Borrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.